Biochemical research of hepatoprotective activity of Lavaflam tablets in rats with subchronic hepatitis

1. Chalasani N, Younossi Z, Lavine J, Diehl AM, Brunt E, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases. American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005-23.10.1002/hep.2576222488764Search in Google Scholar

2. Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterol. 2015;148:547-55.10.1053/j.gastro.2014.11.03925461851Search in Google Scholar

3. Habior A. Diseases of the liver of a threat in Europe in the twenty-first century. Achievements in the Field of Medical Sciences. 2009;2: 1977-83.Search in Google Scholar

4. Petri A, Sabin K. Visual statistics in medicine. Moscow: Geotar-Media; 2003. p. 143.10.1309/2Y22-Y89D-0K4F-86PLSearch in Google Scholar

5. Aslanian MA, Bobrytska L, Goncharov МІ, Nazarova ES, Popova NV, Litvinenko VI. Medicinal product of choleretic effect № u201409419. Patent 97298 Ukraine, MPК А 61 К 36/53. bulletin №5.Search in Google Scholar

6. Aslanyan M, Bobrytska L, Hrytsenko V, Shpychak O, Popova N, Germanyuk T, et al. Technological aspects of development of a new drug in tablets called “Lavaflam” and its pharmaco-economic evaluation. Res J Pharm Bioll Chem Sci. 2017;4(8):808-14.Search in Google Scholar

7. Stefanov OV. Preclinical research of medicines. Moscow: Geotar Media; 2001. p.528.Search in Google Scholar

8. Rikalo NA. Experimental model of chronic tetrachloromethane hepatitis and liver cirrhosis in non-pregnant rats. Bull Ukr Med Stomatol Acad. 2009;9;116-8.Search in Google Scholar

9. European convention for the protection of vertebrate animals used for experimental and other scientific purposes. European Treaty Series -No. 123. Strasbourg: Council of Europe; 1986.Search in Google Scholar

10. Abrashova TV, Gushchin YaA, Kovaleva MA, Rybakova AV, Selezneva AI, Sokolova AP, Hodko SV. Preclinical studies. Directory physiological, biochemical and biometric indices of the norm of experimental animals. Moscow: Geotar Media; 2013. p. 118.Search in Google Scholar

11. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Amer J Clin Path. 1957;28:56.10.1093/ajcp/28.1.5613458125Search in Google Scholar

12. Reference book for clinical and biochemical research and laboratory diagnostics. Medpressinform; 2009.Search in Google Scholar

13. Severina ES. Biochemistry. Moscow: Geotar Media; 2003.Search in Google Scholar

14. Chevari S, Chaba I, Sekeĭ I. The role of superoxide dismutase in the oxidative processes of the cell and the method for its determination in biological materials. Lab Delo. 1985;11:678-81.Search in Google Scholar

15. Nishiki M, Rao NA, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys Res Com. 1972;46:849-54.Search in Google Scholar

16. Kamishnikov VS. Reference book for clinical and biochemical research and laboratory diagnostics. Moscow: Medpressinform; 2009.Search in Google Scholar

17. Abrashova TV, Gushchin YaA, Kovaleva MA, Rybakova AV, Selezneva AI, Sokolova AP, Hodko SV. Preclinical studies. Background Physiological, Biochemical and Biometric Indices of the Experimental Animals’ Standard. 2013;118.Search in Google Scholar

18. Harutyunyan AB, Dubinina EE, Zybinka IM. Methods of estimation of free radical processes in an organism: methodical recommendations. Foliant. 2000;103.Search in Google Scholar

19. Stalnaya ID, Garishvili TG. Method for the determination of malondialdehyde with tiobarbituric acid/ID. in ed. Orehovich VN. (ed) Modern Methods in Biochemistry. 1977. p.66-68.Search in Google Scholar

20. Kamyshnikov VS. Handbook on Clinical-Biochemical Laboratory Diagnostics. 2003;495.Search in Google Scholar

21. Skoy NY. Chronic diseases of the biliary tract. Pathogenesis and laboratory diagnostics. 1972;229.Search in Google Scholar

22. Rebrova OY. Statistical analysis of medical data. Application of the application package Statistica. Moscow: Mediasfera Publ; 2006.Search in Google Scholar

23. Ivko T, Aslanian M, Bobrytska L, Popova N, Nazarova O, Bereznyakova N, Germanyuk Т. Development of the composition and manufacturing technology of a new combined drug: Lavaflam. Turk J Pharm Sci. 2018;15(3):263-27010.4274/tjps.79553722784032454669Search in Google Scholar

24. Aslanian MA, Bobrytska LA, Bereznyakova NL, Shpychak OS, Hrytsenko VІ, Germanyuk TA, Ivko TI. Histological research of hepatoprotective activity of tablets Lavaflam in rats with subchronic hepatitis. Zaporozhye Med J. 2018;2:182-187.10.14739/2310-1210.2018.02.124940Search in Google Scholar

25. Arakelyan MA, Bobrytska LO, Popova NV. Marketing research of the market of drugs with the choleretic action. News of Pharmacy. 2014;2:63-67.Search in Google Scholar